Westend Capital Management’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.98K Hold
29
﹤0.01% 203
2025
Q4
$3.63K Buy
29
+3
+12% +$382 ﹤0.01% 202
2025
Q3
$3.48K Sell
26
-4,806
-99% -$631K ﹤0.01% 213
2025
Q2
$657K Sell
4,832
-57
-1% -$7.52K 0.2% 30
2025
Q1
$649K Buy
4,889
+2,800
+134% +$356K 0.25% 27
2024
Q4
$236K Hold
2,089
0.07% 41
2024
Q3
$238K Hold
2,089
0.08% 44
2024
Q2
$216K Buy
2,089
+2,032
+3,565% +$215K 0.08% 38
2024
Q1
$6.48K Buy
+57
New +$6.53K ﹤0.01% 147

Other funds holding ABT

Westend Capital Management's ABT Position: Q1 2026 in Review

Westend Capital Management held its Abbott (ABT) position steady in Q1 2026 at 29 shares worth $2.98K. The position accounts for ﹤0.01% of the portfolio, ranked #203.

Westend Capital Management first reported a position in ABT in Q1 2024 and has held it in 9 quarters since. The position peaked at $657K in Q2 2025. 3,086 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Westend Capital Management held 29 shares of Abbott worth $2.98K as of Q1 2026.
  • Westend Capital Management left its Abbott share count unchanged in Q1 2026.
  • Abbott made up ﹤0.01% of Westend Capital Management's portfolio in Q1 2026, its #203 holding.
  • Westend Capital Management first reported a position in Abbott in Q1 2024 and has held it in 9 quarters since.
  • Westend Capital Management's Abbott position peaked at $657K in Q2 2025.
  • 3,086 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Westend Capital Management's 13F filing for Q1 2026, filed 14 Apr 2026.